A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Phase 3
Completed
- Conditions
- Psoriasis
- Registration Number
- NCT00293891
- Lead Sponsor
- Astellas Pharma Inc
- Brief Summary
A study to assess the safety and effectiveness of tacrolimus cream in the treatment of psoriasis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 658
Inclusion Criteria
- Clinical diagnosis of plaque psoriasis
Exclusion Criteria
- Skin disorder other than plaque psoriasis in the areas to be treated.
- Disease on only elbows, knees, and scalp
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method